Richard Klausner, Director at Juno Therapeutics, Inc. (JUNO), sold 8,000 shares at $53.33 ($427K) on 2015-07-15, disclosed to the SEC on 2015-07-17.
Scheduled sale ($427k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.33 | 7,883 | $420K | 98.5% |
| 2 | $53.94 | 117 | $6K | 1.5% |
| Total | $53.34 avg | 8,000 | $427K | 100% |
| Filing → |
| LYEL | SELL | 2022-09-27 | $71K | — | Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |